ABSTRACT
We investigate a hybrid device allowing a photon-phonon coupling of a transmission line radiation (TLR) and a nanoeletromechanical system (NEMS), mediated by a superconducting qubit population imbalance. We demonstrate the derivation of an effective Hamiltonian for the strongly dispersive regime for this system. The qubit works as a quantum switch, allowing a conditioned transfer of excitations between the TLR and NEMS. We show that this regime allows the system to be employed for signal processing and force estimation. Additionally, we explore the ability of the quantum switch to generate non-classical states.
ABSTRACT
The artificial intelligence (AI) tools based on large-language models may serve as a demonstration that we are reaching a groundbreaking new paradigm in which machines themselves will generate knowledge autonomously. This statement is based on the assumption that the ability to master natural languages is the ultimate frontier for this new paradigm and perhaps an essential step to achieving the so-called general artificial intelligence. Autonomous knowledge generation implies that a machine will be able, for instance, to retrieve and understand the contents of the scientific literature and provide interpretations for existing data, allowing it to propose and address new scientific problems. While one may assume that the continued development of AI tools exploiting large-language models, with more data used for training, may lead these systems to learn autonomously, this learning can be accelerated by devising human-assisted strategies to deal with specific tasks. For example, strategies may be implemented for AI tools to emulate the analysis of multivariate data by human experts or in identifying and explaining patterns in temporal series. In addition to generic AI tools, such as Chat AIs, one may conceive personal AI agents, potentially working together, that are likely to serve end users in the near future. In this perspective paper, we discuss the development of this type of agent, focusing on its architecture and requirements. As a proof-of-concept, we exemplify how such an AI agent could work to assist researchers in materials sciences.
Subject(s)
Artificial Intelligence , Materials Science , Humans , Language , Learning , Research PersonnelABSTRACT
In this study, we investigated the infection by pulmonary parasites in the water snake Helicops angulatus. We found four nymphs of the pentastomide parasite Sebekia oxycephala, parasitizing two adult females H. angulatus collected in the municipality of Rio Tinto, Paraíba, Brazil. This occurrence is likely due to the nymphs of this parasite directly infecting aquatic intermediate hosts, such as fish. The result of this study represents the first record of pentastomid infecting H. angulatus.
Subject(s)
Colubridae , Pentastomida , Animals , Female , Colubridae/parasitology , Brazil/epidemiology , Lung , NymphABSTRACT
Doxorubicin (DOX) is a chemotherapeutic agent that has been used in the treatment of breast cancer. However, serious toxic effects have limited its use, mainly cardiotoxicity. To minimize the adverse effects, liposomal preparations containing DOX have been developed. These preparations can reach the target in the tumor region as well as bypass the resistance-related problems. An alternative to increased therapeutic efficacy may be the fusion of liposomes with exosomes released from tumor cells to facilitate membrane and fusion interactions, achieving greater cell uptake. Thus, the purpose of this study was the fusion of exosomes derived from breast tumor cells with long-circulating and pH-sensitive liposomes loading DOX (ExoSpHL-DOX) for the treatment of breast cancer. The mean diameter of ExoSpHL-DOX was 100.8 ± 7.8 nm, the polydispersity index was 0.122 ± 0.004, and the encapsulated DOX content was equal to 83.5 ± 2.5%. The fusion of exosomes with long-circulating and pH-sensitive liposomes was confirmed by Fourier transform infrared spectroscopy, Raman spectroscopy, and nano-flow cytometry. The physicochemical characteristics of ExoSpHL-DOX were maintained for 60 days, at 4 °C. The study of the release of DOX from ExoSpHL-DOX in dilution media with different pH values showed the pH sensitivity characteristic of the nanosystem, since 96.6 ± 0.2% of DOX was released from ExoSpHL-DOX at pH 5.0, while at pH 7.4, the release was 70.1 ± 1.7% in the medium. The cytotoxic study against the breast cancer cell line demonstrated that ExoSpHL-DOX treatment significantly reduced the cancer cell viability.
Subject(s)
Antineoplastic Agents , Breast Neoplasms , Exosomes , Antineoplastic Agents/therapeutic use , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Doxorubicin/chemistry , Doxorubicin/pharmacology , Exosomes/pathology , Female , Humans , Hydrogen-Ion Concentration , Liposomes/chemistryABSTRACT
We apply estimation theory to a system formed by two interacting trapped ions. By using the Fisher matrix formalism, we introduce a simple scheme for estimation of the temperature of the longitudinal vibrational modes of the ions. We use the ions interaction to effectively infer the temperature of the individual ions, by optimising the interaction time evolution and by measuring only over one of the ions. We also investigate the effect of a non-thermal reservoir over the inference approach. The non-classicality of one of the ions vibrational modes, introduced due to a squeezed thermal reservoir, does not directly affect the inference of the individual temperatures, although allowing the modes to be entangled. To check actual experimental conditions, we analyze the temperature inference under heating due to surface-electrode noise.
ABSTRACT
Pioglitazone, an agonist at peroxisome proliferator-activated receptor gamma, is FDA-approved for the treatment of insulin resistance in type 2 diabetes. Numerous studies in male rodents suggest that pioglitazone inhibits inflammatory and neuropathic pain, but few included female subjects. To address this gap, we compared the effects of pioglitazone in both sexes in the intraplantar methylglyoxal model (MG) model of chemical pain and painful diabetic neuropathy (PDN), the plantar incision model (PIM) of postoperative pain, the spared nerve injury (SNI) model of traumatic nerve injury, and the ZDF rat and db/db mouse models of PDN. We administered pioglitazone by one-time intrathecal or intraperitoneal injection or by adding it to chow for 6 weeks, followed by measurement of hypersensitivity to non-noxious mechanical, noxious mechanical, heat, and/or cold stimuli. In all mouse models, injection of pioglitazone decreased pain-like behaviors with greater potency and/or efficacy in females as compared to males: heat and mechanical hypersensitivity in the MG model (0.1-10 mg/kg); mechanical hypersensitivity in the PIM model (10 µg); mechanical and cold hypersensitivity in the SNI model (100 mg/kg); and heat hypersensitivity in the db/db model (100 mg/kg). Furthermore, co-administration of low doses of morphine (1 mg/kg) and pioglitazone (10 mg/kg) decreased SNI-induced mechanical and cold hypersensitivity in female but not male mice. In the ZDF rat, pioglitazone (100 mg/kg) decreased heat and mechanical hypersensitivity with no sex difference. In the db/db model, pioglitazone had no effect when given into chow for 6 weeks at 0.3, 3 or 30 mg/kg doses. We conclude that females exhibit greater anti-hyperalgesic responses to pioglitazone in mouse models of chemical-induced nociception, postsurgical pain, neuropathic pain, and PDN. These findings set the stage for clinical trials to determine whether pioglitazone has analgesic properties across a broad spectrum of chronic pain conditions, particularly in women.
Subject(s)
Analgesics/pharmacology , Hyperalgesia/drug therapy , Neuralgia/drug therapy , Nociceptive Pain/drug therapy , PPAR gamma/agonists , Pain, Postoperative/drug therapy , Pioglitazone/pharmacology , Analgesics/administration & dosage , Animals , Diabetic Neuropathies/complications , Disease Models, Animal , Female , Male , Mice , Morphine/pharmacology , Neuralgia/etiology , Nociceptive Pain/chemically induced , Pain, Postoperative/etiology , Peripheral Nerve Injuries/complications , Pioglitazone/administration & dosage , Pyruvaldehyde/pharmacology , Sex CharacteristicsABSTRACT
The objective of this study was to evaluate the different lactation stages of F1 Holstein x Zebu cows on intake and digestibility of nutrients, nitrogen use efficiency, feeding behavior and performance. Thirty-six F1 Holstein × Zebu cows with initial body weight (BW) of 482±43kg were used. The early, mid and late lactation stages were characterized after 50±13, 111.5±11.75 and 183.0±17.5 days in milk, respectively. A completely randomized design with three lactation stages and 12 cows in each treatment group was used. Dry matter intake (P=0.01) was higher in late lactation. Milk yield (P<0.01) was 24.17% higher in early lactation than in other stages. Body weight was lowest in mid-lactation cows (465.63kg; P<0.01). The feed efficiency was 23.36% higher in early lactation than in other stages (0.82kg of milk/kg of DM). F1 Holstein x Zebu cows have increased dry matter intake in late lactation. Milk yield and feed efficiency in early lactation were benefited by changes in feeding behavior, such as increased rumination time.(AU)
O objetivo deste estudo foi avaliar os diferentes estágios de lactação de vacas F1 Holandês x Zebu quanto ao consumo e à digestibilidade de nutrientes, à eficiência no uso de nitrogênio, ao comportamento ingestivo e ao desempenho. Trinta e seis vacas F1 Holandês × Zebu, com peso corporal inicial (PC) de 482±43kg, foram utilizadas. Os estágios inicial, médio e final da lactação foram caracterizados após 50±13, 111,5±11,75 e 183,0±17,5 dias de lactação, respectivamente. O arranjo experimental adotado foi o delineamento inteiramente ao acaso, com três fases de lactação e 12 vacas em cada grupo de tratamento. O consumo de matéria seca (P=0,01) foi maior no período final da lactação. Na fase inicial da lactação, a produção de leite (P<0,01) foi maior em 24,17% em comparação às demais fases. Na fase intermediária da lactação, as vacas apresentaram menor peso corporal (465,63kg; P<0,01) em relação às demais fases. A eficiência alimentar foi maior em 23,36% na fase inicial da lactação (0,82kg de leite/kg de MS). Vacas F1 Holandês x Zebu aumentam o consumo de matéria seca no período final da lactação. A produção de leite e a eficiência alimentar no início da lactação foram favorecidas por mudanças no comportamento ingestivo, como o aumento do tempo de ruminação.(AU)
Subject(s)
Animals , Female , Cattle , Nutrients , Feeding Behavior , Nitrogen/administration & dosage , Lactation , Crosses, GeneticABSTRACT
The objective of this study was to evaluate the different lactation stages of F1 Holstein x Zebu cows on intake and digestibility of nutrients, nitrogen use efficiency, feeding behavior and performance. Thirty-six F1 Holstein × Zebu cows with initial body weight (BW) of 482±43kg were used. The early, mid and late lactation stages were characterized after 50±13, 111.5±11.75 and 183.0±17.5 days in milk, respectively. A completely randomized design with three lactation stages and 12 cows in each treatment group was used. Dry matter intake (P=0.01) was higher in late lactation. Milk yield (P<0.01) was 24.17% higher in early lactation than in other stages. Body weight was lowest in mid-lactation cows (465.63kg; P<0.01). The feed efficiency was 23.36% higher in early lactation than in other stages (0.82kg of milk/kg of DM). F1 Holstein x Zebu cows have increased dry matter intake in late lactation. Milk yield and feed efficiency in early lactation were benefited by changes in feeding behavior, such as increased rumination time.(AU)
O objetivo deste estudo foi avaliar os diferentes estágios de lactação de vacas F1 Holandês x Zebu quanto ao consumo e à digestibilidade de nutrientes, à eficiência no uso de nitrogênio, ao comportamento ingestivo e ao desempenho. Trinta e seis vacas F1 Holandês × Zebu, com peso corporal inicial (PC) de 482±43kg, foram utilizadas. Os estágios inicial, médio e final da lactação foram caracterizados após 50±13, 111,5±11,75 e 183,0±17,5 dias de lactação, respectivamente. O arranjo experimental adotado foi o delineamento inteiramente ao acaso, com três fases de lactação e 12 vacas em cada grupo de tratamento. O consumo de matéria seca (P=0,01) foi maior no período final da lactação. Na fase inicial da lactação, a produção de leite (P<0,01) foi maior em 24,17% em comparação às demais fases. Na fase intermediária da lactação, as vacas apresentaram menor peso corporal (465,63kg; P<0,01) em relação às demais fases. A eficiência alimentar foi maior em 23,36% na fase inicial da lactação (0,82kg de leite/kg de MS). Vacas F1 Holandês x Zebu aumentam o consumo de matéria seca no período final da lactação. A produção de leite e a eficiência alimentar no início da lactação foram favorecidas por mudanças no comportamento ingestivo, como o aumento do tempo de ruminação.(AU)
Subject(s)
Animals , Female , Cattle , Nutrients , Feeding Behavior , Nitrogen/administration & dosage , Lactation , Crosses, GeneticABSTRACT
SETTING: Rio de Janeiro, RJ, Brazil, a high tuberculosis (TB) burden city.OBJECTIVE: To compare the sociodemographics, clinical characteristics, care process indicators (CPIs) and treatment outcomes among adolescents with pulmonary TB (PTB) and those with PTB + extrapulmonary TB (EPTB), who underwent testing with Xpert® and sputum culture.DESIGN: This was a retrospective study of data from three national databases from 2014 to 2016 of adolescents (aged 10-18 years) residing and notified in Rio de Janeiro City. Three groups were identified according to their Xpert and culture results: Group 1, Xpert- and culture-positive; Group 2, Xpert-positive and culture-negative; and Group 3, Xpert- and culture-negative. Study CPIs were as follows: the time between 'sample collection and Xpert result release', 'sample collection and treatment initiation' and 'notification and treatment outcome'.RESULTS: Of 258 adolescents included in the study, 223 (86.4%) were in Group 1, 20 (7.8%) in Group 2 and 15 (5.8%) in Group 3. Groups 1 and 2 had a similar profile. Compared to Group 1, Group 3 had a higher proportion of HIV-positive cases (21.4% vs. 3.0%, P = 0.016), adolescents with a hospital diagnosis (53.3% vs. 7.6%, P < 0.001), and PTB + EPTB cases (20% vs. 0.4%; P < 0.001). There were no statistically significant differences in CPIs or treatment outcomes.CONCLUSION: The clinical diagnosis was decisive in more critical or complex patients, despite Xpert-negative results.
Subject(s)
Molecular Diagnostic Techniques , Sputum/microbiology , Tuberculosis, Pulmonary/diagnosis , Tuberculosis/diagnosis , Adolescent , Brazil/epidemiology , Child , Female , HIV Infections/epidemiology , Humans , Male , Retrospective Studies , Tuberculosis/epidemiology , Tuberculosis, Pulmonary/epidemiologyABSTRACT
The use of different types of concentrated supplements on the performance of Nellore calves grazing Urochloa brizantha cv. Marandu in the dry season was evaluated. The experiment was conducted on 24 ha divided into 12 paddocks. Seventy-two calves with initial body weight (BW) 176±14kg for 140 days of experiment were used. Evaluated treatments included: Mineral, Salt+urea (mineral with 30% urea), Protein (supplementation with 45% crude protein (CP) and 46% total digestible nutrients (TDN)); and Protein+energy (with 28% CP and 73% TDN). The Mineral, Salt+urea, and Protein were offered ad libitum, and the Protein+energy 5g/kg BW. Protein+energy showed the highest (P< 0.05) intake (3.66g/kg BW) followed by the Protein (1.61), Salt+urea (0.36), and Mineral (0.32). The two latter supplements were not significantly different (P> 0.05). The highest (P< 0.05) average daily gain (ADG, kg/day) was observed in the Protein+energy (0.074). Average daily gains for the Protein and Salt+urea (0.014 and -0.024, respectively) were not significantly different (P> 0.05), but were significantly higher (P< 0.05) than the Mineral (-0.085). Therefore, during the dry season, to prevent the loss of bovine weight the supplements must supply in addition to minerals, also energy, non-protein nitrogen (NNP), and true protein.(AU)
Foi avaliada a utilização de tipos de suplementos concentrados sobre o desempenho de bezerros Nelore em pasto de Urochloa brizantha cv. Marandu na época seca. O experimento foi conduzido em 24ha divididos em 12 piquetes. Foram utilizados 72 bezerros com peso corporal (PC) inicial de 176±14kg por 140 dias de experimento. Os tratamentos foram: mineral, mineral+ureia (mineral com 30% de ureia); proteinado (suplemento com 45% de PB e 46% de nutrientes digestíveis totais (NDT)); suplemento energético (suplemento com 28% de PB e 73% de NDT). Mineral, mineral+ureia e proteinado foram fornecidos ad libitum, e o suplemento proteico-energético 5g/kg de PC. O consumo do suplemento (g/kg de PC) foi maior (P<0,05) para o suplemento proteico-energético (3,66), seguido por proteinado (1,61), mineral+ureia (0,36) e mineral (0,32). Esses dois últimos não diferiram entre si (P>0,05). O maior (P<0,05) GMD (kg/dia) foi para o suplemento proteico-energético (0,074), seguido por proteinado e mineral+ureia (0,014 e -0,024, respectivamente), que não diferiram entre si (P>0,05). Todos estes foram superiores (P<0,05) ao mineral (-0,085). Assim, durante a época seca, para prevenir a perda de peso de bovinos, os suplementos devem fornecer, além de minerais, energia, nitrogênio não proteico (NNP) e proteína verdadeira.(AU)
Subject(s)
Animals , Cattle , Cattle/growth & development , Pasture/analysis , Dietary Supplements/analysisABSTRACT
The use of different types of concentrated supplements on the performance of Nellore calves grazing Urochloa brizantha cv. Marandu in the dry season was evaluated. The experiment was conducted on 24 ha divided into 12 paddocks. Seventy-two calves with initial body weight (BW) 176±14kg for 140 days of experiment were used. Evaluated treatments included: Mineral, Salt+urea (mineral with 30% urea), Protein (supplementation with 45% crude protein (CP) and 46% total digestible nutrients (TDN)); and Protein+energy (with 28% CP and 73% TDN). The Mineral, Salt+urea, and Protein were offered ad libitum, and the Protein+energy 5g/kg BW. Protein+energy showed the highest (P< 0.05) intake (3.66g/kg BW) followed by the Protein (1.61), Salt+urea (0.36), and Mineral (0.32). The two latter supplements were not significantly different (P> 0.05). The highest (P< 0.05) average daily gain (ADG, kg/day) was observed in the Protein+energy (0.074). Average daily gains for the Protein and Salt+urea (0.014 and -0.024, respectively) were not significantly different (P> 0.05), but were significantly higher (P< 0.05) than the Mineral (-0.085). Therefore, during the dry season, to prevent the loss of bovine weight the supplements must supply in addition to minerals, also energy, non-protein nitrogen (NNP), and true protein.(AU)
Foi avaliada a utilização de tipos de suplementos concentrados sobre o desempenho de bezerros Nelore em pasto de Urochloa brizantha cv. Marandu na época seca. O experimento foi conduzido em 24ha divididos em 12 piquetes. Foram utilizados 72 bezerros com peso corporal (PC) inicial de 176±14kg por 140 dias de experimento. Os tratamentos foram: mineral, mineral+ureia (mineral com 30% de ureia); proteinado (suplemento com 45% de PB e 46% de nutrientes digestíveis totais (NDT)); suplemento energético (suplemento com 28% de PB e 73% de NDT). Mineral, mineral+ureia e proteinado foram fornecidos ad libitum, e o suplemento proteico-energético 5g/kg de PC. O consumo do suplemento (g/kg de PC) foi maior (P<0,05) para o suplemento proteico-energético (3,66), seguido por proteinado (1,61), mineral+ureia (0,36) e mineral (0,32). Esses dois últimos não diferiram entre si (P>0,05). O maior (P<0,05) GMD (kg/dia) foi para o suplemento proteico-energético (0,074), seguido por proteinado e mineral+ureia (0,014 e -0,024, respectivamente), que não diferiram entre si (P>0,05). Todos estes foram superiores (P<0,05) ao mineral (-0,085). Assim, durante a época seca, para prevenir a perda de peso de bovinos, os suplementos devem fornecer, além de minerais, energia, nitrogênio não proteico (NNP) e proteína verdadeira.(AU)
Subject(s)
Animals , Cattle , Cattle/growth & development , Pasture/analysis , Dietary Supplements/analysisABSTRACT
The Maytenus genus is a member of the Celastraceae family. Numerous medicinal uses were assigned to species of this genus, with the use of roots, bark, and leaves for the treatment of gastric ulcers, as anti-inflammatory, analgesic, antiallergic, antitumor, among others. Several studies have demonstrated that natural products derived from plants have an important role in the prevention and treatment of obesity. Accordingly, we evaluated the effect of Maytenus imbricata extracts in the treatment of obesity induced by diet rich in refined carbohydrate (HC). BALB/c mice were fed chow or HC diet for 8 weeks. At the beginning of the 9th week, the HC group was subdivided into three groups: (i) group of animals that continued to consume only HC diet; (ii) the group of animals fed HC diet supplemented with ethyl acetate extract of M. imbricata roots (HC + EAE); (iii) the group of animals fed HC diet supplemented with extract in hexane/ethyl ether (HC + HEE). The period of extracts supplementation was 4 weeks. It was observed that EAE and EHE when added to the HC diet modulated the metabolic and inflammatory changes, such as: reduced the adipocytes area, improved glucose intolerance, reduced the levels of triglycerides and resistin in serum, and the number of total leukocytes in blood. In the epididymal adipose tissue, the extracts reduced proinflammatory mediators' concentration. According to the results, it was concluded that the species Maytenus imbricata has the potential to be used for the treatment of obesity.
Subject(s)
Celastraceae/chemistry , Inflammation/drug therapy , Maytenus/chemistry , Metabolic Diseases/drug therapy , Plant Extracts/pharmacology , Adipose Tissue/drug effects , Adipose Tissue/metabolism , Animals , Carbohydrates/pharmacology , Diet/adverse effects , Dietary Supplements , Inflammation/metabolism , Insulin Resistance/physiology , Male , Metabolic Diseases/metabolism , Mice , Mice, Inbred BALB C , Triglycerides/metabolismABSTRACT
Pesticides are used worldwide to control arthropod parasites in cattle herds. The indiscriminate and/or inappropriate use of pesticides without veterinary guidance is a reality in several countries of South America. Improper pesticide use increases the chances of contamination of food and the environment with chemical pesticides and their metabolites. Reduction of these contamination events is an increasing challenge for those involved in livestock production. The horn fly, Haematobia irritans (Linnaeus) (Diptera: Muscidae), is one of the most economically important parasites affecting cattle herds around the world. As such, horn fly control efforts are often required to promote the best productive performance of herds. Pesticide susceptibility bioassays revealed that pyrethroid resistance was widespread and reached high levels in horn fly populations in the Brazilian state of Rondônia. The knockdown resistance (kdr) sodium channel gene mutation was detected in all horn fly populations studied (n = 48), and the super kdr sodium channel gene mutation was found in all homozygous resistant kdr individuals (n = 204). Organophosphate resistance was not identified in any of the fly populations evaluated.
Subject(s)
Insecticide Resistance/genetics , Insecticides/pharmacology , Muscidae/drug effects , Organophosphates/pharmacology , Pyrethrins/pharmacology , Animals , Brazil , Muscidae/geneticsABSTRACT
BACKGROUND: Posterior urethral valves (PUVs) constitute the most common infravesical urinary obstruction in boys and are often accompanied by severe consequences to the lower and upper urinary tract. Currently, about two-thirds of diagnosis of PUVs has been suspected by prenatal ultrasonography findings. The aim of this study was to compare long-term clinical outcomes in two groups of patients with PUVs, with antenatal vs. postnatal diagnosis. STUDY DESIGN: This was a retrospective cohort study of 173 patients with PUVs systematically followed up in a tertiary center. Median follow-up time was 66.5 months (interquartile range [IQ], 11.4-147.9 months) for those patients who survived neonatal period. Seventy-nine (45.6%) patients were followed up for more than 5 years and 55 (32%) for more than 10 years. For analysis, the cohort was stratified into two groups according to the clinical presentation (prenatal vs. postnatal). The events of interest were urinary tract infection (UTI), surgical interventions, proteinuria, hypertension, chronic kidney disease (CKD), and death. Survival analyses were performed to evaluate time until occurrence of the events. RESULTS: Sixty-two patients (35.8%) were diagnosed by fetal sonography. Patients of postnatal group presented a higher incidence rate of UTI episodes (6.5, 95% confidence interval [CI], 4.9-8.3) than antenatal group (1.2, 95% CI, 0.4-2.7) (P < 0.001). Thirty-six patients (21%) presented hypertension, and 77 (44.5%) had persistent mild proteinuria. There was no significant difference in the estimated incidence of hypertension (P = 0.28) and proteinuria (P = 0.78) between antenatal and postnatal groups. The cumulative incidence of CKD stage ≥3 was estimated to be about 37% at 10 years of age, and 56% at 18 years of age. By survival analysis, there was no significant difference in the estimated incidence of CKD stage ≥3 (log-rank = 0.32, P = 0.57) and CKD stage 5 (log-rank = 1.08, P = 0.28, Figure) between antenatal and postnatal groups. Of 173 patients included in the analysis, 13 (7.5%) died during follow-up with a median age of 2.6 months (IQ, 15 days-62 months). Survival analyses have not shown any significant difference in the estimated incidence of death between antenatal and postnatal groups (log-rank = 1.38, P = 0.24). CONCLUSION: The study findings did not corroborate the initial hypothesis that the rates of renal function declining in patients with PUVs would be attenuated by an early diagnosis and intervention after antenatal diagnosis.
Subject(s)
Ultrasonography, Prenatal , Urethra/abnormalities , Urethra/diagnostic imaging , Urologic Diseases/epidemiology , Adolescent , Child , Child, Preschool , Cohort Studies , Female , Humans , Incidence , Infant , Infant, Newborn , Male , Pregnancy , Retrospective Studies , Treatment Outcome , Urethra/surgery , Urethral Obstruction/complications , Urethral Obstruction/epidemiology , Urethral Obstruction/surgery , Urologic Diseases/complications , Urologic Diseases/surgeryABSTRACT
Cancer is an important public health problem, being one of the leading causes of death worldwide. Most antineoplastic agents cause severe toxic effects and some types of cancer do not respond or are resistant to the existing pharmacotherapy, necessitating the research and development of new therapeutic strategies. Cardenolides have shown significant antitumor activity due to their ability to inhibit the Na+K+ATPase enzyme, and the expression of this enzyme is increased in tumor cells. Glucoevatromonoside containing peracetylated glucose hydroxyl groups (GEVPG) is a cardenolide derivative that has low solubility in aqueous media, which constitutes a barrier to its potential biological applications. In this context, the use of liposomes represents a promising strategy to deliver GEVPG, thus allowing its intravenous administration. In this study, long-circulating and fusogenic liposomes containing GEVPG (SpHL-GEVPG) were developed, and their chemical and physicochemical properties were evaluated. SpHL-GEVPG presented adequate properties, including a mean diameter of 182.2 ± 2.7 nm, a polydispersity index equal to 0.36 ± 0.03, a zeta potential of -2.37 ± 0.31 mV, and a GEVPG entrapment of 0.38 ± 0.04 mg/mL. Moreover, this formulation showed a good stability after having been stored for 30 days at 4 °C. The cytotoxic studies against breast (MDA-MB-231, MCF-7, and SKBR-3) and lung (A549) cancer cell lines demonstrated that SpHL-GEVPG treatment significantly reduced the cell viability. In addition, the SpHL-GEVPG formulation presented a good selectivity toward these cancer cells. The evaluation of the therapeutic efficacy of the treatment with SpHL-GEVPG showed a potent anticancer effect in an A549 human lung cancer xenograft model. SpHL-GEVPG administered at doses of 1.0 and 2.0 mg/kg (i.v.) induced antitumor effect comparable to paclitaxel given at dose of 10 mg/kg (i.v.) to mice. Therefore, the results of the present work indicate the potential applicability of SpHL-GEVPG as a new anticancer formulation.
Subject(s)
Antineoplastic Agents/pharmacology , Cardenolides/pharmacology , Liposomes/chemistry , Animals , Antineoplastic Agents/chemistry , Cardenolides/chemistry , Cell Death , Cell Line, Tumor , Cell Proliferation/drug effects , Female , Humans , Inhibitory Concentration 50 , Mice, Inbred BALB C , Particle Size , Tumor Burden , Xenograft Model Antitumor AssaysABSTRACT
Despite the great diversity of plant growth-promoting bacteria (PGPB) with potential to partially replace the use of N fertilisers in agriculture, few PGPB have been explored for the production of commercial inoculants, reinforcing the importance of identifying positive plant-bacteria interactions. Aiming to better understand the influence of PGPB inoculation in plant development, two PGPB species with distant phylogenetic relationship were inoculated in maize. Maize seeds were inoculated with Bacillus sp. or Azospirillum brasilense. After germination, the plants were subjected to two N treatments: full (N+) and limiting (N-) N supply. Then, anatomical, biometric and physiological analyses were performed. Both PGPB species modified the anatomical pattern of roots, as verified by the higher metaxylem vessel element (MVE) number. Bacillus sp. also increased the MVE area in maize roots. Under N+ conditions, both PGPB decreased leaf protein content and led to development of shorter roots; however, Bacillus sp. increased root and shoot dry weight, whereas A. brasilense increased photosynthesis rate and leaf nitrate content. In plants subjected to N limitation (N-), photosynthesis rate and photosystem II efficiency increased in maize inoculated with Bacillus sp., whilst A. brasilense contained higher ammonium, amino acids and total soluble sugars in leaves, compared to the control. Plant developmental and metabolical patterns were switched by the inoculation, regardless of the inoculant bacterium used, producing similar as well as distinct modifications to the parameters studied. These results indicate that even non-diazotrophic inoculant strains can improve the plant N status as result of the morpho-anatomical and physiological modifications produced by the PGPB.
Subject(s)
Azospirillum brasilense/metabolism , Bacillus/metabolism , Nitrogen/pharmacology , Plant Roots/anatomy & histology , Zea mays/microbiology , Plant Roots/drug effects , Plant Roots/growth & development , Plant Roots/metabolism , Zea mays/growth & development , Zea mays/metabolism , Zea mays/physiologyABSTRACT
Pituitary adenomas account for 10-15% of primary intracranial tumors. Growth hormone (GH)-secreting adenomas account for 13% of all pituitary adenomas and cause acromegaly. These tumors can be aggressive, invade surrounding structures and are highly recurrent. The objective of this study was to evaluate E-cadherin, Slug and neural cell adhesion molecule (NCAM) expression in GH-secreting pituitary adenomas and its relationship to tumor invasiveness. A cross-sectional study of patients who underwent hypophysectomy due to GH-secreting pituitary adenoma from April 2007 to December 2014 was carried out. The medical records were reviewed to collect clinical data. Immediately after surgery, tumor samples were frozen in liquid nitrogen and stored in a biofreezer at -80°C for assessment of E-cadherin 1 (CDH1), SLUG (SNAI2), and NCAM (NCAM1) by real-time PCR. The samples were fixed in formalin and embedded in paraffin for immunohistochemical analysis of E-cadherin and NCAM. Thirty-five patients with acromegaly were included in the study. Of these, 65.7% had invasive tumors. Immunohistochemically, E-cadherin was expressed in 96.7% of patients, and NCAM in 80% of patients. There was no statistically significant relationship between tumor grade or invasiveness and immunohistochemical expression of these markers. Regarding gene expression, 50% of cases expressed CDH1, none expressed SNAI2, and 53.3% expressed NCAM1. There was no statistically significant relationship between tumor grade or invasiveness and gene expression of CDH1, SNAI2, and NCAM1. The absence of Slug overexpression and of E-cadherin and NCAM suppression suggests that expression of these markers is not associated with tumor invasiveness in GH-secreting pituitary adenomas.
Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Young Adult , Acromegaly/pathology , Adenoma/pathology , Cadherins/analysis , Neural Cell Adhesion Molecules/analysis , Snail Family Transcription Factors/analysis , Acromegaly/genetics , Acromegaly/metabolism , Immunohistochemistry , Biomarkers, Tumor/analysis , Adenoma/genetics , Adenoma/chemistry , Gene Expression , Cross-Sectional Studies , Neoplasm GradingABSTRACT
Pituitary adenomas account for 10-15% of primary intracranial tumors. Growth hormone (GH)-secreting adenomas account for 13% of all pituitary adenomas and cause acromegaly. These tumors can be aggressive, invade surrounding structures and are highly recurrent. The objective of this study was to evaluate E-cadherin, Slug and neural cell adhesion molecule (NCAM) expression in GH-secreting pituitary adenomas and its relationship to tumor invasiveness. A cross-sectional study of patients who underwent hypophysectomy due to GH-secreting pituitary adenoma from April 2007 to December 2014 was carried out. The medical records were reviewed to collect clinical data. Immediately after surgery, tumor samples were frozen in liquid nitrogen and stored in a biofreezer at -80°C for assessment of E-cadherin 1 (CDH1), SLUG (SNAI2), and NCAM (NCAM1) by real-time PCR. The samples were fixed in formalin and embedded in paraffin for immunohistochemical analysis of E-cadherin and NCAM. Thirty-five patients with acromegaly were included in the study. Of these, 65.7% had invasive tumors. Immunohistochemically, E-cadherin was expressed in 96.7% of patients, and NCAM in 80% of patients. There was no statistically significant relationship between tumor grade or invasiveness and immunohistochemical expression of these markers. Regarding gene expression, 50% of cases expressed CDH1, none expressed SNAI2, and 53.3% expressed NCAM1. There was no statistically significant relationship between tumor grade or invasiveness and gene expression of CDH1, SNAI2, and NCAM1. The absence of Slug overexpression and of E-cadherin and NCAM suppression suggests that expression of these markers is not associated with tumor invasiveness in GH-secreting pituitary adenomas.
Subject(s)
Acromegaly/pathology , Adenoma/pathology , Cadherins/analysis , Neural Cell Adhesion Molecules/analysis , Pituitary Neoplasms/pathology , Snail Family Transcription Factors/analysis , Acromegaly/genetics , Acromegaly/metabolism , Adenoma/chemistry , Adenoma/genetics , Adolescent , Adult , Aged , Biomarkers, Tumor/analysis , CD56 Antigen/analysis , Cross-Sectional Studies , Female , Gene Expression , Humans , Immunohistochemistry , Male , Middle Aged , Neoplasm Grading , Neoplasm Invasiveness , Pituitary Neoplasms/chemistry , Pituitary Neoplasms/genetics , Real-Time Polymerase Chain Reaction , Statistics, Nonparametric , Young AdultABSTRACT
The aim of this study was to determine the isotopic-turnover rate (RIT ) and trophic-discrimination factor (FTD ) in muscle tissues of Lebranche mullet Mugil liza fed an experimental diet (δ13 C = -27·1; δ15 N = 1·0). Juvenile M. liza exhibited a relatively fast RIT , with a half-life (t50 ) of only 16 and 14 days for δ13 C and δ15 N respectively and a nearly complete isotopic turnover (t95 ) of 68 and 60 days for δ13 C and δ15 N.